303 related articles for article (PubMed ID: 25496315)
21. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.
Tsurusaki Y; Okamoto N; Ohashi H; Kosho T; Imai Y; Hibi-Ko Y; Kaname T; Naritomi K; Kawame H; Wakui K; Fukushima Y; Homma T; Kato M; Hiraki Y; Yamagata T; Yano S; Mizuno S; Sakazume S; Ishii T; Nagai T; Shiina M; Ogata K; Ohta T; Niikawa N; Miyatake S; Okada I; Mizuguchi T; Doi H; Saitsu H; Miyake N; Matsumoto N
Nat Genet; 2012 Mar; 44(4):376-8. PubMed ID: 22426308
[TBL] [Abstract][Full Text] [Related]
22. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
[TBL] [Abstract][Full Text] [Related]
23. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
DeCristofaro MF; Betz BL; Wang W; Weissman BE
Oncogene; 1999 Dec; 18(52):7559-65. PubMed ID: 10602515
[TBL] [Abstract][Full Text] [Related]
24. Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion.
Bosse KR; Shukla AR; Pawel B; Chikwava KR; Santi M; Tooke L; Castagna K; Biegel JA; Bagatell R
Cancer Genet; 2014 Sep; 207(9):415-9. PubMed ID: 25018128
[TBL] [Abstract][Full Text] [Related]
25. INI1-deficient tumors: diagnostic features and molecular genetics.
Hollmann TJ; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
[No Abstract] [Full Text] [Related]
27. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
[TBL] [Abstract][Full Text] [Related]
28. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
[TBL] [Abstract][Full Text] [Related]
29. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.
Wu X; Dagar V; Algar E; Muscat A; Bandopadhayay P; Ashley D; Wo Chow C
Pathology; 2008 Dec; 40(7):664-70. PubMed ID: 18985520
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.
McKenna ES; Tamayo P; Cho YJ; Tillman EJ; Mora-Blanco EL; Sansam CG; Koellhoffer EC; Pomeroy SL; Roberts CW
Cell Cycle; 2012 May; 11(10):1956-65. PubMed ID: 22544318
[TBL] [Abstract][Full Text] [Related]
31. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
32. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium.
Donner LR; Wainwright LM; Zhang F; Biegel JA
Hum Pathol; 2007 Jun; 38(6):935-9. PubMed ID: 17376508
[TBL] [Abstract][Full Text] [Related]
33. The SWI/SNF complex and cancer.
Reisman D; Glaros S; Thompson EA
Oncogene; 2009 Apr; 28(14):1653-68. PubMed ID: 19234488
[TBL] [Abstract][Full Text] [Related]
34. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
[TBL] [Abstract][Full Text] [Related]
35. SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy.
Soto-Castillo JJ; Llavata-Marti L; Fort-Culillas R; Andreu-Cobo P; Moreno R; Codony C; García Del Muro X; Alemany R; Piulats JM; Martin-Liberal J
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446319
[TBL] [Abstract][Full Text] [Related]
36. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers.
Lee RS; Stewart C; Carter SL; Ambrogio L; Cibulskis K; Sougnez C; Lawrence MS; Auclair D; Mora J; Golub TR; Biegel JA; Getz G; Roberts CW
J Clin Invest; 2012 Aug; 122(8):2983-8. PubMed ID: 22797305
[TBL] [Abstract][Full Text] [Related]
37. Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosis.
Savage N; Linn D; McDonough C; Donohoe JM; Franco A; Reuter V; Biddinger PW; Eaton KW; Biegel JA; Sharma S
Ann Diagn Pathol; 2012 Dec; 16(6):504-7. PubMed ID: 21775180
[TBL] [Abstract][Full Text] [Related]
38. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.
Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA
Clin Cancer Res; 2009 Mar; 15(6):1923-30. PubMed ID: 19276269
[TBL] [Abstract][Full Text] [Related]
39. SWI/SNF-deficient tumors of the central nervous system: An update.
Hasselblatt M; Kool M; Frühwald MC
Clin Neuropathol; 2024; 43(1):2-9. PubMed ID: 37969088
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
